VJHemOnc is committed to improving our service to you

SOHO 2018 | The unmet needs in low-risk MDS

VJHemOnc is committed to improving our service to you

David Steensma

Speaking from the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting, held in Houston, TX, David Steensma, MD, of the Dana-Farber Cancer Institute, Boston, MA, highlights the unmet needs in low-risk myelodysplastic syndromes (MDS) currently. Dr Steensma discusses relapse following hypomethylating agent treatment, transfusion-dependence and iron overload, and those with low neutrophil and platelet counts.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter